Tower Research Capital (TRC)’s CapForce IBD 50 ETF FFTY Stock Holding History

Tower Research Capital (TRC)’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Sell	3,219 -25,506	-89%	-$1M	﹤0.01%	1948
2026 Q1	$960K	Buy	28,725 +17,869	+165%	+$664K	0.02%	554
2025 Q4	$378K	Buy	10,856 +3,556	+49%	+$131K	0.01%	995
2025 Q3	$273K	Buy	7,300 +7,200	+7,200%	+$249K	0.01%	1247
2025 Q2	$3.25K	Sell	100 -14,432	-99%	-$412K	﹤0.01%	4529
2025 Q1	$392K	Sell	14,532 -693	-5%	-$20.3K	0.01%	983
2024 Q4	$435K	Buy	15,225 +4,883	+47%	+$142K	0.01%	1162
2024 Q3	$278K	Sell	10,342 -9,780	-49%	-$257K	0.01%	1321
2024 Q2	$559K	Buy	20,122 +1,981	+11%	+$54K	0.01%	1247
2024 Q1	$501K	Buy	18,141 +1,699	+10%	+$44.4K	0.01%	861
2023 Q4	$401K	Buy	16,442 +43	+0.3%	+$978	﹤0.01%	1551
2023 Q3	$367K	Buy	+16,399	New	+$396K	0.01%	1057
2023 Q2	–	Sell	-23,298	Closed	-$551K	–	6136
2023 Q1	$551K	Sell	23,298 -12,767	-35%	-$293K	0.02%	768
2022 Q4	$787K	Buy	36,065 +6,340	+21%	+$156K	0.03%	476
2022 Q3	$727K	Buy	29,725 +6,042	+26%	+$167K	0.01%	867
2022 Q2	$636K	Buy	23,683 +6,265	+36%	+$201K	0.01%	978
2022 Q1	$680K	Buy	17,418 +463	+3%	+$18K	0.01%	976
2021 Q4	$778K	Buy	16,955 +16,737	+7,678%	+$799K	0.01%	840
2021 Q3	$10K	Sell	218 -39,511	-99%	-$1.85M	﹤0.01%	4311
2021 Q2	$1.84M	Buy	39,729 +27,306	+220%	+$1.24M	0.05%	340
2021 Q1	$545K	Buy	+12,423	New	+$564K	0.01%	1172
2020 Q4	–	Sell	-18,668	Closed	-$696K	–	5205
2020 Q3	$696K	Buy	18,668 +9,289	+99%	+$342K	0.01%	1320
2020 Q2	$323K	Sell	9,379 -33,627	-78%	-$1.04M	0.01%	1379
2020 Q1	$1.2M	Buy	43,006 +30,076	+233%	+$1M	0.07%	191
2019 Q4	$449K	Sell	12,930 -48,558	-79%	-$1.64M	0.04%	296
2019 Q3	$1.99M	Buy	61,488 +27,249	+80%	+$932K	0.14%	121
2019 Q2	$1.17M	Buy	34,239 +18,511	+118%	+$624K	0.08%	222
2019 Q1	$527K	Sell	15,728 -61,830	-80%	-$1.95M	0.03%	569
2018 Q4	$2.14M	Buy	+77,558	New	+$2.41M	0.15%	133

Other funds holding FFTY

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $171M AUM 36.85% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return

Tower Research Capital (TRC)'s FFTY Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its CapForce IBD 50 ETF (FFTY) stake by 89% in Q2 2026, selling an estimated $1M and leaving 3,219 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Tower Research Capital (TRC) first reported a position in FFTY in Q4 2018 and has held it in 29 quarters since. The position peaked at $2.14M in Q4 2018. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

Tower Research Capital (TRC) held 3,219 shares of CapForce IBD 50 ETF worth $140K as of Q2 2026.
Tower Research Capital (TRC) sold 25,506 CapForce IBD 50 ETF shares in Q2 2026, an estimated $1M.
CapForce IBD 50 ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1948 holding.
Tower Research Capital (TRC) first reported a position in CapForce IBD 50 ETF in Q4 2018 and has held it in 29 quarters since.
Tower Research Capital (TRC)'s CapForce IBD 50 ETF position peaked at $2.14M in Q4 2018.
33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.